Advances in Biomarkers and Anti BCMA Therapeutics to Improve Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Mar 22, 2022

- Mar 21, 2023

1.0

Claim your AMA PRA Category 1 Credit(s) or CNE Contact Hour(s) credit

This course is available for logged in users only. Please login or register to take the course.

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

MANAGEMENT OF PSVT: UPDATE FROM ACC25

Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist